Results 181 to 190 of about 3,232,246 (219)

Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy

Molecular Oncology, EarlyView.
We developed a scalable workflow to generate proinflammatory human myeloid cells. CRISPR/Cas9‐edited CD34+ hematopoietic stem and progenitor cells were expanded and differentiated with M‐CSF. Deletion of STAT6 or STAT6/NFKB1 enhanced macrophage proinflammatory gene expression and cytokine secretion in the presence of IL‐4 while maintaining antibody ...
Theresa Barberi, Alan D. Friedman
wiley   +1 more source

Risk Stratification Based on Endoscopic Ulcerative Findings in Patients with Endoscopic Non-Complete Response after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. [PDF]

J Anus Rectum Colon
Kido K, Chino A, Akiyoshi T, Tokura J, Suzuki K, Ishioka M, Ide D, Taguchi S, Osumi H, Shinozaki E, Takamatsu M, Saito S.   +11 more
europepmc   +1 more source

Catalytic Stereoselective Intermolecular Fluoroacylation of Unactivated Alkynes via C-F Bond Reconstruction. [PDF]

Org Lett
Kanji T, Alharthi AA, Husayni AH, Wainwright P, Wirth T, Melen RL, Morrill LC.   +6 more
europepmc   +1 more source

Platelet-related extracellular vesicles: Therapeutic roles in musculoskeletal disorders. [PDF]

Regen Ther
Meng T, Wang Y, Tang X, Xiong J, Hu S.
europepmc   +1 more source

Coexisting Moderate-to-Severe Tricuspid Regurgitation and Renal Dysfunction Identify a High-Risk Group After Transcatheter Aortic Valve Replacement. [PDF]

J Cardiovasc Dev Dis
Lauten P, Markus B, Chatzis G, Syntila S, Schieffer B, Mihali K, Kreutz J.   +6 more
europepmc   +1 more source

Association of Predicted Surgical Risk With 3-Year Outcomes After Isolated Tricuspid Valve Surgery: An Analysis of Medicare Beneficiaries. [PDF]

JACC Adv
Mehaffey JH, Cohen DJ, Davidson C, Hahn R, Daggubati R, Hayanga JW, Badhwar V.   +6 more
europepmc   +1 more source